Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $5.32 -0.15 (-2.82%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 119.67%, with a year-to-date return of 67.70%. In the past month, the stock has decreased 1.17%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $5.47 with a market cap of $196.70 million and volume of 13,160 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.37%1 Month Performance-1.17%3 Month Performance+37.01%Year-To-Date Performance+67.70%1 Year Performance+119.67% EPRX Stock Chart for Friday, September, 12, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$5.32$5.47+2.82%$5.55$5.4113,160 shs$196.70 million09/10/2025$5.27$5.32+0.99%$5.38$5.2111,521 shs$191.31 million09/09/2025$5.27$5.27-0.04%$5.32$5.155,481 shs$189.44 million09/08/2025$5.39$5.27-2.23%$5.37$5.226,214 shs$189.51 million09/05/2025$5.36$5.39+0.56%$5.41$5.3030,300 shs$193.82 million09/04/2025$5.40$5.36-0.74%$5.45$5.3020,241 shs$192.75 million09/03/2025$5.41$5.40-0.18%$5.46$5.3735,071 shs$194.18 million09/02/2025$5.36$5.41+0.93%$5.48$5.3919,573 shs$194.54 million09/01/2025$5.36$5.36$5.42$5.1216,816 shs$192.75 million08/29/2025$5.27$5.36+1.71%$5.42$5.1216,816 shs$192.75 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$5.28$5.27-0.19%$5.28$5.251,817 shs$189.51 million08/27/2025$5.05$5.28+4.55%$5.34$5.0717,955 shs$189.87 million08/26/2025$5.18$5.05-2.51%$5.20$5.058,410 shs$181.60 million08/25/2025$5.28$5.18-1.89%$5.39$5.045,840 shs$186.27 million08/22/2025$5.20$5.28+1.54%$5.36$5.233,916 shs$189.87 million08/21/2025$5.30$5.20-1.89%$5.40$5.1721,057 shs$186.99 million08/20/2025$5.38$5.30-1.49%$5.46$5.304,677 shs$190.59 million08/19/2025$5.30$5.38+1.51%$5.42$5.2210,344 shs$193.47 million08/18/2025$5.32$5.30-0.38%$5.45$5.237,228 shs$190.59 million08/15/2025$5.28$5.32+0.76%$5.40$5.272,219 shs$191.31 million08/14/2025$5.45$5.28-3.12%$5.56$5.274,093 shs$189.87 million08/13/2025$5.38$5.45+1.32%$5.58$5.416,637 shs$195.98 million08/12/2025$5.32$5.38+1.11%$5.41$5.2118,142 shs$193.43 million08/11/2025$5.26$5.32+1.14%$5.42$5.2015,869 shs$191.31 million Related Companies Niagen Bioscience Stock Chart Day One Biopharmaceuticals Stock Chart Vir Biotechnology Stock Chart Arbutus Biopharma Stock Chart Valneva Stock Chart Tango Therapeutics Stock Chart BGM Group Stock Chart Kura Oncology Stock Chart GH Research Stock Chart Nurix Therapeutics Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts